Popular Articles

Neurocrine Announces Full Year Results From 603 Study (Petal Study) Of Elagolix For Treatment Of Endometriosis Pain
Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced additional positive safety and efficacy results from its Phase IIb clinical trial known as the Petal Study (603 study) using its proprietary, orally-active non-peptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis. The Petal Study enrolled 252 patients, with a confirmed diagnosis of endometriosis, into three treatment groups; elagolix 150 mg once daily, elagolix 75 mg twice daily, or depo-subQ provera 104(TM) (DMPA) for six months of treatment followed by six months of no treatment. Database lock and unblinding of the full 48 week data set has provided more insight on the clinical benefits and safety profile of elagolix for the treatment of pain associated with endometriosis.

UC Davis Researchers Develop New Test For Fragile X Syndrome
Researchers at UC Davis have developed a new test that will measure the protein deficit responsible for fragile X syndrome - the single-most common cause of intellectual impairment and the most-commonly inherited cause of autism. The test, described in a study appearing online in the July 2009 issue of The Journal of Molecular Diagnostics, is the first to measure an individual"s level of the fragile X mental retardation 1 (FMR1) protein.
News of the day
Discretionary Fortification Of Junk Food With Vitamin And Mineral Could Be Approved By Health Canada
Health Canada considers permitting vitamin and mineral (iron, calcium etc.) additives in high-calorie food products of all sorts, such as potato chips, energy bars, fruit flavored drinks. However dieticians and other health professionals caution that those products continue to be fortified junk food and that the little added nutritional value will boost consumption and enhance problems of obesity and diabetes.
Sexual Health

British Medical Association Responds To Government's Working Time Directive Training Review

Responding to Health Secretary Alan Johnson"s announcement of a review on the impact of the European Working Time Directive on doctors" training, Dr Andy Thornley, Chair of the BMA"s Junior Doctors Committee, said: "The NHS has had 11 years to prepare for the full implementation of the European Working Time Directive. Whilst we are pleased to see the government finally respond to concerns about the implementation of the directive and the impact it will have on junior doctors" training, this announcement comes just 10 weeks before the 48-hour week becomes UK law. "Junior doctors currently deliver a large proportion of service in hospitals, but they also need time to train to become the consultants and GPs of tomorrow. The reduction in hours that has occurred in preparation for the directive has left many juniors frustrated at the lack of training opportunities as hospitals struggle to maintain the same levels of service in a 48-hour week. "The BMA has repeatedly called on the government to take doctors" concerns about the impact of the directive on training seriously. Whilst a review will be helpful we have proposed a range of practical changes to help protect the standards of junior doctor training. We cannot afford for the high standards of care that patients expect from doctors to be eroded because of poor preparations for the 48-hour limit. "The re-introduction of training lists, for example, would ensure that trainees are able to perform procedures which are suitable for their stage of training. We have proposed increasing the flexibility of training programmes so that doctors can take more time to progress and gain appropriate experience. It is also crucial that the NHS invests in simulators and skills labs, where doctors can practise techniques using technology which simulates a procedure or operation, and that consultant trainers have protected time to supervise junior doctors. "We also need to look at how healthcare is delivered in the NHS. The heavy reliance on junior doctors to provide service to patients will need to move towards a system that is more reliant on consultant based care. To achieve this, the NHS will need to look at focused consultant expansion. "We hope the review will move swiftly so that there is time to implement the range of practical changes that the BMA has been proposing before the August 1st deadline." British Medical Association

RES Course Provider commented:

You have focused on a relevant topic. I have learnt a lot through this post. Thanks for the brilliant sharing.

25.04.2012


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):